The third edition of PSYCH Symposium, held on December 4 at London’s Conway Hall, reflected a field in transition.
This article was made possible thanks to on-site reporting by Sasha Mbilika.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
At PSYCH Symposium in the British Museum on 6 July a conversation between Professor Robin Carhart-Harris and journalist Kate Spicer explored the impact of psychedelic research...
In light of clinical research showing MDMA-assisted therapy as a potential treatment for PTSD, at PSYCH Symposium in the British Museum on 6 July a conversation...
At PSYCH Symposium in the British Museum on 6 July, the panel ‘Neuroimaging & Psychedelics: The Past, Present & Future’ explored how neuroimaging can inform our...
PSYCH Symposium’s afternoon panels saw discussions continue the exploration of the landscape of psychedelic healthcare.
PSYCH Symposium returned at the British Museum on 6 July to explore how psychedelic medicines can innovate healthcare – from mental health to eating disorders and...
PSYCH Symposium: London 2023 brought together key stakeholders to explore the landscape of psychedelic medicine at the British Museum on Thursday, 6 July.
Psychedelic Medicine Investment Fund Negev Capital is aiming to innovate mental healthcare in Europe by providing funding to companies on the cutting edge of psychedelic research.
